2 results
Approved WMORecruiting
Currently, CMR examinations often contain non-evaluable sequences not suited for diagnosis due patient motion resulting from failure to maintain breath-hold. By reducing scan time and increasing patient comfort, diagnostic value will increase at…
Approved WMOCompleted
To characterize the safety, tolerability, and recommended phase 2 dose (RP2D) of each combination partner used with ruxolitinib (Part 1)To evaluate the preliminary efficacy of each novel ruxolitinib combination treatment arm (Parts 2 & 3)